We have also demonstrated important role of the Akt/mTOR pathway in anal cancer progression, and its inhibition by rapamycin treatment results in delayed cancer progression indicating therapeutic potential of rapamycin in treating anal cancer. Here, MTOR is linked to anal carcinoma.